Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 11/20 | 0.39 |
| ▸ | MAOA | P21397 | 9/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1914223 | 0.93 | MAOA (0.34) | MAOBMAOAALDH1A1KDM4EUSP2 | |
| SCHEMBL2793117 | 0.84 | ALDH1A1 (0.58) | MAOBMAOAALDH1A1KDM4EUSP2 | |
| SCHEMBL30150359 | 0.84 | ALDH1A1 (0.58) | MAOBMAOAALDH1A1KDM4EUSP2 | |
| SCHEMBL20364829 | 0.84 | IMPDH2 (0.39) | MAOBMAOAALDH1A1TRPV4 | |
| SCHEMBL31352953 | 0.84 | IMPDH2 (0.39) | MAOBMAOAALDH1A1TRPV4 | |
| SCHEMBL30488974 | 0.82 | IMPDH2 (0.45) | MAOBMAOAALDH1A1KDM4EUSP2 | |
| SCHEMBL818327 | 0.82 | IMPDH2 (0.45) | MAOBMAOAALDH1A1KDM4EUSP2 | |
| SCHEMBL2390105 | 0.80 | TRPV4 (0.53) | TRPV4 | |
| SCHEMBL14183919 | 0.80 | TSHR (0.45) | ALDH1A1KDM4EUSP2 | |
| SCHEMBL23797569 | 0.80 | TSHR (0.45) | ALDH1A1KDM4EUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3300157-B1 | NON-AQUEOUS ELECTROLYTE ADDITIVE, NON-AQUEOUS ELECTROLYTE CONTAINING SAME FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY | LG CHEMICAL LTD (KR) | 2019-10-16 | — | — | EP | disclosed |
| EP-3300157-B1 | NON-AQUEOUS ELECTROLYTE ADDITIVE, NON-AQUEOUS ELECTROLYTE CONTAINING SAME FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY | LG CHEMICAL LTD (KR) | 2019-10-16 | — | — | EP | disclosed |
| US-20180198157-A1 | NON-AQUEOUS ELECTROLYTE ADDITIVE, AND NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY COMPRISING THE SAME AND LITHIUM SECONDARY BATTERY | LG CHEM, LTD. (KR) | 2018-07-12 | — | — | US | disclosed |
| US-20180198157-A1 | NON-AQUEOUS ELECTROLYTE ADDITIVE, AND NON-AQUEOUS ELECTROLYTE FOR LITHIUM SECONDARY BATTERY COMPRISING THE SAME AND LITHIUM SECONDARY BATTERY | LG CHEM, LTD. (KR) | 2018-07-12 | — | — | US | disclosed |
| EP-3300157-A2 | NON-AQUEOUS ELECTROLYTE ADDITIVE, NON-AQUEOUS ELECTROLYTE CONTAINING SAME FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY | LG Chem, Ltd. (KR) | 2018-03-28 | — | — | EP | disclosed |
| US-8383658-B2 | Isoxazole based neuronal nicotinic receptor ligands and methods of use | ABBOTT LABORATORIES (US) | 2013-02-26 | — | — | US | disclosed |
| WO-2009149135-A1 | BIS (HETERO ) ARYL SUBSTITUTED ISOXAZOLES FOR USE AS NEURONAL NICOTINIC RECEPTOR MODULATORS | ABBOTT LABORATORIES (US) | 2009-12-10 | — | — | WO | disclosed |
| US-20090306096-A1 | Novel Isoxazoles and Methods of Use Thereof | ABBOTT LABORATORIES (US) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306096-A1 | Novel Isoxazoles and Methods of Use Thereof | XDH, PRDX5, CYP4X1 | MAOB 470/4885MAOA 508/4885ALDH1A1 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.